Course Provider
ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.
ATMA Journey Centres sits in the more practice-facing end of the psychedelic training field: clinically grounded, Canada-led, and unusually close to real-world service delivery. Its appeal is strongest for licensed clinicians and prescribers who want a structured route into regulated psychedelic-assisted therapy, rather than a purely academic or retreat-style introduction. The lineage looks fairly credible, with programme figures including Ben Malcolm, Pam Kryskow, Mark Haden, and, for the MDMA workshop, Scott Shannon and Jason Sienknecht. That said, much of the public-facing positioning is promotional, so the best read is as a serious practitioner pathway with a clinic-network angle, not a neutral university-style qualification.
Best suited to licensed therapists, psychologists, counsellors, social workers, physicians, psychiatrists, nurse practitioners, and adjacent wellness professionals who want to work in or alongside regulated psychedelic-assisted therapy. It is less obviously aimed at the curious public and more at practitioners seeking a practical route into clinical use.
The Foundations course is described as the starting point for all pathways and accessible to mental health or wellness professionals. The Clinical Pathway is for licensed therapists, psychologists, counsellors, and social workers; the Prescriber Pathway is for physicians, psychiatrists, and nurse practitioners; the Integrative Pathway is for coaches, addictions counsellors, and allied health practitioners. The sources do not state hard admission checks beyond role fit, but the provider says it offers advisor support on credentials and requirements.
ATMA CENA states that its programmes are accredited and eligible for CE or CME credits depending on designation. It says the Clinical and Integrative pathways are CE-eligible and the Prescriber Pathway is CME-eligible. The company also states it is fully licensed under Alberta’s PDTS framework, the Edmonton clinic has achieved accreditation, and the Calgary clinic is undergoing accreditation through CPSA-guided processes.
Publicly listed prices found: Psychedelic-Assisted Therapy Foundations is CAD 800 plus tax, one-time, and Prescribing & Oversight in Psychedelic-Assisted Therapy is CAD 4,000 plus tax, one-time. The Foundations course includes 14 modules, 14 to 21 CE credits depending on the page version, and lifetime access to materials; the prescriber course includes 10 modules, 40 CE credits, three live Q&A sessions, two self-care sessions, and a certificate of completion. Some pages indicate bundle discounts and other courses or immersive add-ons, but full pathway pricing is not clearly published in the sources reviewed.
Learners walk away with course completion certificates, CE or CME credits where applicable, and a foundation in the history, science, ethics, integration, safety, and clinical application of psychedelic-assisted therapy. More advanced pathways appear to orient learners towards supervised clinical experience and, for prescribers, the ability to evaluate, prescribe, and oversee psychedelic-assisted therapy within interdisciplinary settings.
Linked Courses
2
Active Listings
1
Primary Formats
Hybrid, Live Classes
Programs linked directly to this provider in the Blossom course dataset.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jul 13, 2026
By Atma Journey
The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.